EMERGING DIABETES TRIAL RESULTS AND HOW THEY WILL SHAPE OUR MANAGEMENT STRATEGIES

A Diabetes Breakthrough

L I KA SHING KNOWLEDGE INST ITUTE 209 V ICTORIA STREET, TORONTO M5B 1T8

SATURDAY DECEMBER 8

2018

FACULTYLawrence A. Leiter, MD, FRCPC, FACP, FACE,FAHA, FACCChairEndocrinologist, St. Michael’s HospitalProfessor of Medicine and Nutritional Sciences, University of Toronto,Toronto, ON

Subodh Verma, MD, PhD, FRCSC, FAHACo-Chair Cardiac Surgeon, St. Michael’s HospitalProfessor of Surgery and Pharmacology & Toxicology, University of Toronto, Canada Research Chair in Cardiovascular Surgery Toronto, ON

Peter J. Lin, MD, CCFPDirector, Primary Care Initiatives, Canadian Heart Research CentreMedical Director, LinCorp Medical Inc.Toronto, ON

Ronald M. Goldenberg, MD, FRCPC, FACE Consultant Endocrinologist,North York General Hospital & LMC Diabetes & EndocrinologyVaughan, ON

7:45 am Breakfast and Registration

8:30 am Opening Remarks Dr. Lawrence A. Leiter

8:40 am Diabetes, CV Disease and the Rationale for the DECLARE-TIMI 58 Trial

Dr. Subodh Verma

9:05 am Results from the DECLARE-TIMI 58 Trial

Dr. Stephen D. Wiviott

9:35 am Results from a Meta-Analysis of the SGLT2i CVOTs

Dr. Marc S. Sabatine

10:05 am Nutrition Break

10:35 am Clinical Implications of the DECLARE-TIMI 58 Trial Results

Dr. Lawrence A. Leiter

10:55 am Q&A and Panel Discussion

11:45 am Translating the Evidence into Practice (Case-based presentations with key learnings for primary care practitioners and specialists)

Drs. Subodh Verma, Ronald M. Goldenberg and Peter J. Lin

12:30 pm Closing Remarks Dr. Subodh Verma

AGENDA

Stephen D. Wiviott, MD, FACCCardiologist, Brigham and Women’s HospitalAssociate Professor of Medicine, Harvard Medical SchoolBoston, MA

Marc S. Sabatine,MD, MPH, FACCChairman, TIMI Study GroupLewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine,Brigham and Women’s HospitalProfessor of Medicine,Harvard Medical SchoolBoston, MA

This program has received an educational grant from: AstraZeneca

To register: www.ADiabetesBreakthrough.com

• To review the relationship between diabetes and cardiovascular disease.• To summarise the findings from cardiovascular outcome trials in diabetes that have reported.• To discuss how to implement the clinical trial evidence into everyday practice to optimize diabetes management.

LEARNING OBJECTIVES

This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 3.50 Mainpro+ credits.